Skip to the main content

Aleotti Family

Tuscany Founded 1886 Website
Cheque Size$1M to $50M
Stages3
Industries15
Markets20
Stated Portfolio2
Operating Since1886 (140y)

About Aleotti Family

The Aleotti Family is an Italian family known for their investments in various sectors, including healthcare and technology. They are the owners of Menarini Group, Italy's largest pharmaceutical company, which was founded in 1886 and is headquartered in Florence. The company operates in over 140 countries, producing medicines across cardiology, oncology, gastroenterology, and other therapeutic areas. Under the leadership of Massimiliana Landini Aleotti and her children, Lucia and Alberto Giovanni Aleotti, Menarini has expanded its global presence and diversified its portfolio. The family's investment strategy focuses on sectors such as pharmaceuticals, biotechnology, medical devices, diagnostics, consumer health, chemicals, technology, real estate, energy, telecommunications, media, retail, financial services, and transportation. They have a history of investing in both early-stage and growth-stage companies, with investment sizes ranging from $1 million to $50 million. Their geographical focus includes Italy, the United States, Germany, Spain, France, the United Kingdom, China, Japan, Brazil, Mexico, India, Russia, South Korea, Australia, South Africa, Argentina, Canada, Saudi Arabia, the United Arab Emirates, and Turkey. In recent years, the Aleotti Family has been recognized for their contributions to the pharmaceutical industry. In December 2025, Lucia and Alberto Giovanni Aleotti received the EY Shape the Future Award for their significant contributions to cutting-edge scientific research in healthcare. In October 2025, they were awarded the Italpress Award for Menarini Group's international growth, highlighting their successful guidance of the company toward a global dimension. These accolades reflect the family's commitment to innovation, vision, and the ability to shape the future of the healthcare sector, enhancing people's lives.

Geographical Focus

African markets1

Other stated markets19

United StatesUnited KingdomCanadaGermanyJapanAustraliaChinaIndiaBrazilFranceItalyUnited Arab EmiratesSpainMexicoSouth KoreaSaudi ArabiaTurkeyRussiaArgentina

Requirements

Strong management team, Innovative products or services, Scalable business model, Potential for significant market impact, Alignment with family values and mission

Stated Portfolio2

Berlin-Chemie
Stemline Therapeutics

As reported by the investor. We hold no profile for these companies, so they are printed as stated rather than linked.

Is this you?

Claim this investor profile to manage your firm's information.

Claim this profile
Report an error

Contact

Profile

TypeFamily Office
CityTuscany
Founded1886
Minimum Cheque$1M
Maximum Cheque$50M